Clinical Trial Update: Eradication of Helicobacter Pylori Improves Metabolic Syndrome Through Modulation of Gut Microbiota. [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update on eradication of Helicobacter pylori showing potential improvement in metabolic syndrome through gut microbiota modulation; recru…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Helicobacter Pylori Infection
• Metabolic Syndrome

Snippet

Sponsor: Nanjing First Hospital, Nanjing Medical University | Conditions: HELICOBACTER PYLORI INFECTIONS, Metabolic Syndrome | Phase 4 | Status: RECRUITING